The European Commission approved Pfizer's respiratory syncytial virus vaccine for the prevention of lower respiratory tract ...

Doctors are prescribing antibiotics for tens of thousands of patients with infections, with little or no consideration of ...

Academics called on GPs to ‘better target’ antibiotics for those at highest need after analysing data on millions of ...

Contracting a non-COVID lower respiratory tract infection raises the risk of death 2 to 7 times over the next month to a year ...

Pfizer’s RSV vaccine Abrysvo receives European approval to help protect adults aged 18-59 against RSV lower respiratory tract disease: New York Wednesday, April 2, 2025, 09:00 H ...

Younger people are being increasingly prescribed antibiotics without proper assessment of complication risk, finds a study, ...

Patients hospitalized with CAP who had an LRTS taken on admission exhibited reduced risk of mortality and were more likely to receive appropriate antibiotic therapy.

Pfizer (PFE) announced that the European Commission has issued a decision amending the marketing authorization for Abrysvo, the company’s ...

The following is a summary of “Clinical diagnostic value of throat swabs in pediatric acute lower respiratory tract ...

Pfizer Inc. (NYSE: PFE) announced today that the European Commission (EC) has issued a decision amending the marketing ...